Vista Pharmaceuticals Ltd.

10.00 -0.05 ▼-0.5%

09 June 2023, 04:01:00 PM
Volume: 12,892

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vistapharmaceuticals.com
Market Cap 39.21 Cr.
Enterprise Value(EV) 49.05 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) -1.47 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 33.57 Trailing Twelve Months Ending 2023-03
Book Value / Share 9.17 Trailing Twelve Months Ending 2023-03
Price to Book Value 1.08 Calculated using Price: 9.91
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 3.96 Cr. 39,570,203 Shares
FaceValue 2
About Vista Pharmaceuticals Ltd.
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America.

Vista Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Vista Pharmaceuticals Ltd. Performance

1 Day
-0.50%
1 Week
+12.61%
1 Month
+4.38%
3 Month
+19.33%
6 Month
+21.65%
1 Year
+21.95%
2 Year
-11.89%
5 Year
-73.92%
10 Year
+281.68%

Vista Pharmaceuticals Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 5.27 13.94 7.15 8.97 10.19 3.15 -11.68 -6.43 -2.44
Return on Capital Employed (%) 5.38 14.16 9.57 8.92 12.42 6.28 -5.20 -5.10 -3.63
Return on Assets (%) 3.27 7.39 3.15 3.70 4.67 1.78 -7.11 -3.89 -1.59

Vista Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 9 10 11 17 32 36 30 33 35 37
Non Curr. Liab. 0 0 8 5 6 6 5 11 6 4
Curr. Liab. 5 12 7 19 15 11 16 9 11 15
Minority Int.
Equity & Liab. 14 23 26 41 53 53 51 53 52 55
Non Curr. Assets 12 11 10 16 25 29 30 37 37 34
Curr. Assets 2 12 16 26 28 23 21 15 15 21
Misc. Exp. not W/O
Total Assets 14 23 26 41 53 53 51 53 52 55

Vista Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 8 14 15 24 29 31 23 1 0 1
Other Income 0 0 0 0 0 3 4 0 0 0
Total Income 8 14 15 24 29 34 27 1 1 1
Total Expenditure -7 -11 -13 -21 -24 -30 -28 -3 -2 -3
PBIDT 1 3 3 3 6 4 -1 -2 -1 -2
Interest 0 -1 -1 -2 -2 -2 -2 -1 -1
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -2
Taxation 0 0 0 0 -1 0 0 2 2 -1
Exceptional Items
PAT 0 1 1 1 2 1 -4 -2 -1 -6
Adjusted EPS 0 1 0 0 1 0 -1 -1 0 -2

Vista Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 0 -4 -3 3 -5 3 1 -7 -1
Cash Fr. Inv. 0 0 0 0 -4 -11 -6 -2 0 0
Cash Fr. Finan. 0 4 3 6 11 1 0 7 1
Net Change 0 0 0 5 -4 -1 -1 0 0
Cash & Cash Eqvt 0 0 0 0 6 2 1 0 0 0

Vista Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 35.29 35.29 36.94 36.94 35.44 35.44 35.44 35.44 35.44
Public 64.71 64.71 63.06 63.06 64.56 64.56 64.56 64.56 64.56
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vista Pharmaceuticals Ltd. Announcements

Fri, 09 Jun 2023
Announcement under Regulation 30 (LODR)-Allotment
This is to inform the Exchange(s) that pursuant to the special resolution passed by the members of the Company under Section 62 of the Companies Act 2013 on 14th October 2022 and In- principle approval received from BSE on 30.11.2022 and the allotment of warrants dated 14th December 2022 the allotment of 6 96 870 equity shares of Rs.2/- in the Companys Equity Share Capital on conversion of 6 96 870 Warrants be and are hereby allotted to the person as mentioned below at a price of Rs.10/- per equity shares includes a premium of Rs.8/- per share: for which the Board of Directors have accorded their approval at their meeting held on 09th June 2023 Commenced at 03.00 P.M and Concluded at 03.30 P.M. Sl. No Name of the Allottee No of Equity Shares 1. Mr. Murali Marega (Managing Director) 4 96 8702. Mr. Pavan Sathvik Gilaka (Whole Time Director) 2 00 000 Total 6 96 870
Thu, 01 Jun 2023
Statement Of Deviation Or Variation In Utilization Of Funds Raised Through Preferential Issue Of Equity Shares Of The Company For The Quarter Ended On March 31St 2023.
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 read with SEBI Circular CIR/CFD/CMD1/16212019 dated December 24 2019please find enclosed herewith the Statement of Deviation or Variation in utilization of funds raised through preferential issue of Equity Shares of the Company for the quarter ended on March 3lst 2023.Kindly take the same on record and acknowledge the receipt of the same.
Tue, 30 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance
In compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 and SEBI Circular No. CIR/CFD/CMD/27/2019 dated February 8 2019 please find enclosed herewith copy of Annual Secretarial Compliance Report dated May 30 2023 for the Financial Year 2022-23 issued by our Secretarial Auditor N.V.S.S. Suryanarayana Practicing Company Secretary.

Vista Pharmaceuticals Ltd. Technical Scans

Fri, 09 Jun 2023
High Delivery Percentage High Delivery Percentage
Close Above Last Week High Close Above Last Week High
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
CCI Overbought Zone CCI Overbought Zone

Vista Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 235,890.62 983.15 -0.4%
Divi's Laboratories Ltd. 90,973.43 3,426.90 -2.1%
Cipla Ltd. 78,191.79 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. 77,768.81 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. 70,817.54 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. 61,150.32 1,810.90 +0.8%
Mankind Pharma Ltd. 59,389.24 1,482.30 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.84 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 49.89 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 27.91 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.25 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.63 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 49.23 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 46.32 1,482.30 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7.13 3,426.90 -2.1%
Cipla Ltd. Consolidated 2023-03 3.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.34 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.46 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.89 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2023-03 5.05 1,482.30 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 0.04 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 13.10 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,482.30 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,482.30 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 983.15 -0.4%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,426.90 -2.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 968.65 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,667.90 +0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,934.95 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,810.90 +0.8%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,482.30 +1.8%

Vista Pharmaceuticals Ltd. FAQ's

What is Vista Pharma share price?

Can I buy Vista Pharma shares now?

What is the Market Cap of Vista Pharma?

What are the key metrics to analyse Vista Pharma?

What is the 52 Week High and Low of Vista Pharma?

What is the trend of Vista Pharma share price?